Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 99 (6) , 1757-1762
- https://doi.org/10.1016/0016-5085(90)90484-i
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.Journal of Clinical Investigation, 1990
- ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONSThe Lancet, 1989
- Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels.Journal of Clinical Investigation, 1985
- Pancreatic polypeptide: a unique model for vagal control of endocrine systemsJournal of the Autonomic Nervous System, 1983
- Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody responseJournal of Immunological Methods, 1982
- The Effect of Adrenergic Receptor Blockade on the Exercise-Induced Rise in Pancreatic Polypeptide in Man*Journal of Clinical Endocrinology & Metabolism, 1980
- The importance of cholinergic tone in the release of pancreatic polypeptide by gut hormones in manLife Sciences, 1979
- Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized mealsDigestive Diseases and Sciences, 1979
- Vagovagal Stimulation of Pancreatic-Polypeptide Secretion by Graded Distention of the Gastric Fundus and Antrum in ManDigestion, 1979
- MECHANISM OF PANCREATIC POLYPEPTIDE RELEASE IN MANThe Lancet, 1977